Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Madersbacher

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
European Urology|September 18, 2021
Re: Water Vapor Thermal Therapy to Alleviate Catheter-dependent Urinary Retention Secondary to Benign Prostatic HyperplasiaStephan Madersbacher
European Urology|March 19, 2011
Words of Wisdom. Re: identification of late-onset hypogonadism in middle-aged and elderly menAnton Ponholzer, Stephan Madersbacher
The Journal of Urology|January 23, 2010
Editorial commentAnton Ponholzer, Stephan Madersbacher
Current Opinion in Urology|November 14, 2014
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015Ingrid Schauer, Stephan Madersbacher
BJU International|March 1, 2013
Reply: Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
European Urology|June 14, 2024
The Role of Bladder Outlet Obstruction in Male Non-neurogenic Lower Urinary Tract Symptoms-Any Additional News?Stephan Madersbacher, Matthias Oelke
BJU International|October 11, 2012
Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
European Urology|March 19, 2011
Words of Wisdom. Re: the learning curve for surgical margins after open radical prostatectomy: implications for the use of margin status as an oncologic endpointAnton Ponholzer, Stephan Madersbacher
European Urology|March 30, 2010
Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9Anton Ponholzer, Stephan Madersbacher
European Urology|December 11, 2017
Re: Availability of Evidence of Benefits on Overall Survival and Quality of Life of Cancer Drugs Approved by European Medicines Agency: Retrospective Cohort Study of Drug Approvals 2009-2013Stephan Madersbacher, Gero Kramer
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
European Urology|September 18, 2021
Re: Water Vapor Thermal Therapy to Alleviate Catheter-dependent Urinary Retention Secondary to Benign Prostatic HyperplasiaStephan Madersbacher
European Urology|March 19, 2011
Words of Wisdom. Re: identification of late-onset hypogonadism in middle-aged and elderly menAnton Ponholzer, Stephan Madersbacher
The Journal of Urology|January 23, 2010
Editorial commentAnton Ponholzer, Stephan Madersbacher
Current Opinion in Urology|November 14, 2014
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015Ingrid Schauer, Stephan Madersbacher
BJU International|March 1, 2013
Reply: Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
European Urology|June 14, 2024
The Role of Bladder Outlet Obstruction in Male Non-neurogenic Lower Urinary Tract Symptoms-Any Additional News?Stephan Madersbacher, Matthias Oelke
BJU International|October 11, 2012
Landmarks in hormonal therapy for prostate cancerPeter Hammerer, Stephan Madersbacher
European Urology|March 19, 2011
Words of Wisdom. Re: the learning curve for surgical margins after open radical prostatectomy: implications for the use of margin status as an oncologic endpointAnton Ponholzer, Stephan Madersbacher
European Urology|March 30, 2010
Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9Anton Ponholzer, Stephan Madersbacher
European Urology|December 11, 2017
Re: Availability of Evidence of Benefits on Overall Survival and Quality of Life of Cancer Drugs Approved by European Medicines Agency: Retrospective Cohort Study of Drug Approvals 2009-2013Stephan Madersbacher, Gero Kramer
Pageof 19